New Pharma Tech Survey: Hear from 100+ Investors and Entrepreneurs LEARN MORE

McKesson Ventures
  • Portfolio
  • News & Insights
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Densitas® Selects CancerIQ to Power Lifetime Risk, Patient Adherence as Part of its Industry Leading Mammography Quality AI Platform

by McKesson Ventures | Nov 26, 2023 | Press Releases

Densitas Inc, an artificial intelligence and technology company, announced on Sunday that it has partnered with the cancer prevention service CancerIQ to include Cancer IQ’s Tyrer-Cuzick Version 8 risk calculator in its breast cancer screening offerings. This 8th...

Recent Posts

  • Komodo Health Wins 2026 Fierce AI Innovation Award for Commercial Strategy & Launch from Fierce Pharma
  • Silver and LYNX Launch Production AI Claims Automation to Help TPAs Modernize Claims Processing
  • HarmonyCares Ranks Among Medicare’s Top ACO REACH Performers for 2024
  • UNC Health Scales Medication Access By Over 45% Without Adding Headcount Using Latent Health’s Pharmacy Intelligence Platform
  • Reimagine Care Expands AI-Enabled Virtual Oncology Model with Moffitt Cancer Center Following Strong Patient and Clinical Outcomes
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings